Wysong joins CARE Pharmacies as CEO
ALEXANDRIA, Va. CARE Pharmacies on Friday named Michael Wysong to the position of CEO, effective Sept. 7.
“We are very excited to have Wysong join the CARE team,” stated Molly Carr, CARE chairman and owner of New Hampshire CARE Pharmacy and Medical Equipment. “We are confident his knowledge of community pharmacy will recharge the CARE brand, maximizing our unique position within independent community pharmacy.”
Prior to his appointment at CARE, Wysong served as lead VP retail sales at AmerisourceBergen, and VP sales at Cardinal Health, CARE’s wholesaler.
“It’s an honor to join CARE Pharmacies in their mission of enhancing and promoting retail independent pharmacy,” Wysong said. “This is an important and exciting time to be in the business of providing healthcare services. With the new demands and challenges of healthcare reform, CARE Pharmacies is well-positioned to provide the personalized services and support that our customers will require and deserve.”
MDA offers vouchers for free flu shots at Walgreens
SALT LAKE CITY Walgreens is teaming up with the Muscular Dystrophy Association to administer flu shots to those who need them most, according to published reports.
The MDA is handing out vouchers for free flu shots at Walgreens to those affected by muscular dystrophy and related diseases, according to ABC4News in Salt Lake City.
Voucher requests can be submitted here.
CBO: Generics saved $33 billion for Medicare Part D in 2007
WASHINGTON Generic drugs saved Medicare Part D beneficiaries and the program as a whole $33 billion in 2007, according to a new report by the nonpartisan Congressional Budget Office. The CBO expected another $14 billion in annual savings to accrue as many new generics enter the market through 2012.
The main lobby for pharmacy benefit managers said the report also showed the advantages of pharmacy benefit managers.
“Tools pioneered by pharmacy benefit managers — including encouraging the use of generic medications — have lowered costs and expanded access to prescription drugs for seniors in Medicare Part D,” Pharmaceutical Care Management Association president and CEO Mark Merritt said.
The generic drug industry lobby hailed the report as well. “This new CBO study is just one of a continued body of evidence proving that generics are a key cost-saving component of our healthcare system,” a statement by the Generic Pharmaceutical Association read.
According to the market research firm IMS Health, generic drugs accounted for nearly 75% of prescriptions dispensed in the United States, but for just more than 19% of dollars spent.